减重、生活方式干预与二甲双胍影响胰岛素分泌与敏感性的纵向关系
本研究利用糖尿病预防计划临床试验中2931名2型糖尿病高危成人的资料,在基线及随机化后1、2、3年评估胰岛素分泌与敏感性,并用标准化主轴回归分析二者的非线性关系。结果显示,强化生活方式干预与二甲双胍均降低分泌需求并提高代偿性胰岛素分泌,其中强化生活方式干预作用更大,改善程度与减重量直接相关。代偿性胰岛素分泌增加与体重下降均预测糖尿病风险降低。
要点
- 强化生活方式干预与二甲双胍均降低胰岛素分泌需求并提高代偿性胰岛素分泌,前者作用更大。
- 每减重5 kg,分泌需求降低0.144 SD,代偿性胰岛素分泌增加0.287 SD。
- 代偿性胰岛素分泌增加与减重均预测糖尿病风险降低。
核心结论
- 糖尿病风险的降低与减重量直接相关,该效应由胰岛素敏感性提高所致的分泌需求降低与代偿性胰岛素分泌改善共同介导。
研究设计与样本
- 研究利用糖尿病预防计划临床试验的资料,纳入2931名2型糖尿病高危成人。
- 在基线及随机化后1、2、3年的积极干预阶段,用空腹和负荷后30分钟血清样本的胰岛素与葡萄糖浓度估算胰岛素分泌与敏感性。
- 用标准化主轴回归评估分泌与敏感性的非线性关系,以沿回归线的距离和偏离回归线的距离分别刻画胰岛素分泌需求与代偿性胰岛素分泌。
主要发现
- 强化生活方式干预与二甲双胍均降低分泌需求并提高代偿性胰岛素分泌,强化生活方式干预的作用更大。
- 每减重5 kg,分泌需求降低0.144 SD(95% CI -0.162, -0.125),代偿性胰岛素分泌增加0.287 SD(95% CI 0.261, 0.314)。
- 在时间依赖风险模型中,代偿性胰岛素分泌每增加1个基线SD,糖尿病风险HR=0.166(95% CI 0.133, 0.206);每减重5 kg,HR=0.710(95% CI 0.613, 0.819)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Insulin secretion and sensitivity regulate glycemia, with inadequately compensated deficiencies leading to diabetes. OBJECTIVE: We investigated effects of weight loss, an intensive lifestyle intervention (ILS), and metformin on the relationship between insulin secretion and sensitivity using repository data from 2931 participants in the Diabetes Prevention Program clinical trial in adults at high risk of developing type 2 diabetes. METHODS: Insulin secretion and sensitivity were estimated from insulin and glucose concentrations in fasting and 30-minute postload serum samples at baseline and 1, 2, and 3 years after randomization, during the active intervention phase. The nonlinear relationship of secretion and sensitivity was evaluated by standardized major axis regression to account for variability in both variables. Insulin secretory demand and compensatory insulin secretion were characterized by distances along and away from the regression line, respectively. RESULTS: ILS and metformin decreased secretory demand while increasing compensatory insulin secretion, with greater effects of ILS. Improvements were directly related to weight loss; decreased weight significantly reduced secretory demand (b=-0.144 SD; 95% CI (-0.162, -0.125)/5 kg loss) and increased compensatory insulin secretion (b = 0.287 SD, 95% CI (0.261, 0.314)/5 kg loss). In time-dependent hazard models, increasing compensatory insulin secretion (hazard ratio [HR] = 0.166 per baseline SD, 95% CI 0.133, 0.206) and weight loss (HR = 0.710 per 5 kg loss, 95% CI 0.613, 0.819) predicted lower diabetes risk. CONCLUSION: Diabetes risk reduction was directly related to the amount of weight loss, an effect mediated by lowered insulin secretory demand (due to increased insulin sensitivity) coupled with improved compensatory insulin secretion.
引用
- Vazquez Arreola E, Knowler WC, Hanson RL, et al. Weight Loss, Lifestyle Intervention, and Metformin Affect Longitudinal Relationship of Insulin Secretion and Sensitivity. J Clin Endocrinol Metab. 2022. PMID: 36062951. doi:10.1210/clinem/dgac509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。